HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Fernanda Pessano Fialho Selected Research

2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamide

5/2020Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.
2/2020Topical transient receptor potential ankyrin 1 antagonist treatment attenuates nociception and inflammation in an ultraviolet B radiation-induced burn model in mice.
1/2020TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Fernanda Pessano Fialho Research Topics

Disease

7Pain (Aches)
02/2020 - 01/2017
4Edema (Dropsy)
06/2021 - 09/2019
4Hyperalgesia
02/2020 - 09/2019
2Fatigue
01/2022 - 10/2020
2Inflammation (Inflammations)
01/2022 - 02/2020
2Hypersensitivity (Allergy)
01/2022 - 05/2020
2Multiple Sclerosis
08/2021 - 05/2020
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2021 - 05/2020
2Fibromyalgia (Fibrositis)
10/2020 - 01/2020
2Neuralgia (Stump Neuralgia)
05/2020 - 01/2020
1Neuroinflammatory Diseases
01/2022
1Treatment-Resistant Depressive Disorder
01/2022
1Myalgia
01/2022
1Headache (Headaches)
08/2021
1Malnutrition (Nutritional Deficiencies)
06/2021
1Mitochondrial Diseases (Mitochondrial Disease)
10/2020
1Body Weight (Weight, Body)
10/2020
1Burns
02/2020
1Sunburn
02/2020
1Mental Disorders (Mental Disorder)
01/2020
1Ischemia
09/2019
1Peripheral Nervous System Diseases (PNS Diseases)
02/2019
1Postoperative Pain
02/2019
1Acute Pain
01/2017

Drug/Important Bio-Agent (IBA)

6AnkyrinsIBA
08/2021 - 09/2019
4Freund's AdjuvantIBA
06/2021 - 01/2017
3TRPA1 Cation ChannelIBA
08/2021 - 02/2020
32- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
05/2020 - 01/2020
2Ion Channels (Ion Channel)IBA
08/2021 - 01/2020
2Formaldehyde (Formol)FDA Link
06/2021 - 01/2020
2Reserpine (Serpasil)FDA Link
10/2020 - 01/2020
2acetovanillone (apocynin)IBA
05/2020 - 01/2020
2Thioctic Acid (Lipoic Acid)IBA
05/2020 - 01/2020
2AntioxidantsIBA
05/2020 - 01/2020
2Antisense OligonucleotidesIBA
05/2020 - 01/2020
1Antidepressive Agents (Antidepressants)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
06/2021
1Adenosine Triphosphate (ATP)IBA
10/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020
1Myelin-Oligodendrocyte GlycoproteinIBA
05/2020
1A 967079IBA
05/2020
1AntigensIBA
05/2020
1CalciumIBA
02/2020
1CationsIBA
02/2020
1cinnamaldehyde (cinnamic aldehyde)FDA Link
01/2020
1stephalagineIBA
01/2020
1AlkaloidsIBA
01/2020
1spinasterolIBA
01/2020
1resiniferatoxinIBA
01/2020
1Capsaicin (Zostrix)FDA Link
01/2020
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
09/2019
1AcetoneIBA
09/2019
1prostaglandin-inositol cyclic phosphateIBA
09/2019
1Peptides (Polypeptides)IBA
09/2019
1CTK 01512-2IBA
09/2019
1Lactic Acid (Lactate)FDA LinkGeneric
09/2019
1Paclitaxel (Taxol)FDA LinkGeneric
02/2019
1Complex MixturesIBA
01/2017

Therapy/Procedure

1Therapeutics
01/2020